Dimenhydrinate
Product Images NDC 0924-1007

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Dimenhydrinate (NDC 0924-1007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Acme United Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1006-updated-label (Updated Label 100ct)

1006-updated-label (Updated Label 100ct)
The text is a drug description for a motion sickness medication called MotioniSickness. The medication contains Dimenhydrinate, an antiemetic used for the prevention and treatment of nausea, vomiting, and dizziness associated with motion sickness. The medication comes in tamper-evident packets of 2 tablets, and each tablet contains 50mg of Dimenhydrinate. The drug may cause marked drowsiness and should not be used by individuals under 2 years old, or those with respiratory problems, urination difficulties, or taking sedatives. The medication's first dose should be taken 1-10 hours before starting activity to prevent motion sickness, and the dose should not exceed 8 tablets in 24 hours for adults and children over 12. Children under 12 and over 2 should take one tablet every 6-8 hours, and children under 2 should not use the medication. If overdose happens, medical help or contact with Poison Control Center should be sought. The text also provides contact information for the manufacturer in case of any questions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.